Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021982292> ?p ?o ?g. }
- W2021982292 endingPage "5415" @default.
- W2021982292 startingPage "5409" @default.
- W2021982292 abstract "Abstract Patients with core binding factor acute myeloid leukemia (CBF-AML) benefit from more intensive chemotherapy, but whether both the t(8;21) and inv(16)/t (16;16) subtypes requires intensification remained to be determined. In the 2 successive studies (AML-BFM-1998 and AML-BFM-2004), 220 CBF-AML patients were treated using the same chemotherapy backbone, whereby reinduction with high-dose cytarabine and mitoxantrone (HAM) was scheduled for these cohorts only in study AML-BFM-1998 but not in AML-BFM-2004 against the background to minimize overtreatment. Five-year overall survival (OS) and event-free survival (EFS) were significantly higher and the cumulative incidence of relapse (CIR) lower in t(8;21) patients treated with HAM (n = 78) compared with without HAM (n = 53): OS 92% ± 3% versus 80% ± 6%, plogrank0.047, EFS 84% ± 4% versus 59% ± 7%, plogrank0.001, and CIR 14% ± 4% versus 34% ± 7%, p(gray)0.006. These differences were not seen for inv(16) (n = 43 and 46, respectively): OS 93% ± 4% versus 94% ± 4%, EFS 75% ± 7% versus 71% ± 9% and CIR 15% ± 6% versus 23% ± 8% (not significant). The subtype t(8;21), but not inv(16), was an independent predictor of worse outcome without HAM reinduction. Based on our data, a 5-year OS of > 90% can be expected for CBF-AML, when stratifying t(8;21), but not inv(16), patients to high-risk chemotherapy, including HAM reinduction." @default.
- W2021982292 created "2016-06-24" @default.
- W2021982292 creator A5003366137 @default.
- W2021982292 creator A5009948170 @default.
- W2021982292 creator A5037934940 @default.
- W2021982292 creator A5043053176 @default.
- W2021982292 creator A5045824611 @default.
- W2021982292 creator A5053567227 @default.
- W2021982292 creator A5056686915 @default.
- W2021982292 creator A5062188329 @default.
- W2021982292 creator A5076502958 @default.
- W2021982292 creator A5078683084 @default.
- W2021982292 creator A5090678844 @default.
- W2021982292 date "2011-11-17" @default.
- W2021982292 modified "2023-10-01" @default.
- W2021982292 title "Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)" @default.
- W2021982292 cites W1534965621 @default.
- W2021982292 cites W1784548805 @default.
- W2021982292 cites W1919339218 @default.
- W2021982292 cites W1967486444 @default.
- W2021982292 cites W1983595291 @default.
- W2021982292 cites W1988676466 @default.
- W2021982292 cites W2002766648 @default.
- W2021982292 cites W2017666957 @default.
- W2021982292 cites W2042129979 @default.
- W2021982292 cites W2042814209 @default.
- W2021982292 cites W2061597623 @default.
- W2021982292 cites W2077031414 @default.
- W2021982292 cites W2100663913 @default.
- W2021982292 cites W2102220169 @default.
- W2021982292 cites W2103513114 @default.
- W2021982292 cites W2109602276 @default.
- W2021982292 cites W2109703672 @default.
- W2021982292 cites W2110828128 @default.
- W2021982292 cites W2112266537 @default.
- W2021982292 cites W2127568389 @default.
- W2021982292 cites W2133432816 @default.
- W2021982292 cites W2141838614 @default.
- W2021982292 cites W2144341550 @default.
- W2021982292 cites W2144395887 @default.
- W2021982292 cites W2148047805 @default.
- W2021982292 cites W2157633619 @default.
- W2021982292 cites W2160746673 @default.
- W2021982292 cites W2168891740 @default.
- W2021982292 cites W2318674152 @default.
- W2021982292 cites W2977606681 @default.
- W2021982292 doi "https://doi.org/10.1182/blood-2011-07-364661" @default.
- W2021982292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21948298" @default.
- W2021982292 hasPublicationYear "2011" @default.
- W2021982292 type Work @default.
- W2021982292 sameAs 2021982292 @default.
- W2021982292 citedByCount "54" @default.
- W2021982292 countsByYear W20219822922012 @default.
- W2021982292 countsByYear W20219822922013 @default.
- W2021982292 countsByYear W20219822922014 @default.
- W2021982292 countsByYear W20219822922015 @default.
- W2021982292 countsByYear W20219822922016 @default.
- W2021982292 countsByYear W20219822922017 @default.
- W2021982292 countsByYear W20219822922018 @default.
- W2021982292 countsByYear W20219822922019 @default.
- W2021982292 countsByYear W20219822922020 @default.
- W2021982292 countsByYear W20219822922021 @default.
- W2021982292 countsByYear W20219822922022 @default.
- W2021982292 countsByYear W20219822922023 @default.
- W2021982292 crossrefType "journal-article" @default.
- W2021982292 hasAuthorship W2021982292A5003366137 @default.
- W2021982292 hasAuthorship W2021982292A5009948170 @default.
- W2021982292 hasAuthorship W2021982292A5037934940 @default.
- W2021982292 hasAuthorship W2021982292A5043053176 @default.
- W2021982292 hasAuthorship W2021982292A5045824611 @default.
- W2021982292 hasAuthorship W2021982292A5053567227 @default.
- W2021982292 hasAuthorship W2021982292A5056686915 @default.
- W2021982292 hasAuthorship W2021982292A5062188329 @default.
- W2021982292 hasAuthorship W2021982292A5076502958 @default.
- W2021982292 hasAuthorship W2021982292A5078683084 @default.
- W2021982292 hasAuthorship W2021982292A5090678844 @default.
- W2021982292 hasBestOaLocation W20219822921 @default.
- W2021982292 hasConcept C126322002 @default.
- W2021982292 hasConcept C141071460 @default.
- W2021982292 hasConcept C151032500 @default.
- W2021982292 hasConcept C2776694085 @default.
- W2021982292 hasConcept C2778041864 @default.
- W2021982292 hasConcept C2778729363 @default.
- W2021982292 hasConcept C2780923524 @default.
- W2021982292 hasConcept C71924100 @default.
- W2021982292 hasConcept C72563966 @default.
- W2021982292 hasConcept C88879693 @default.
- W2021982292 hasConcept C90924648 @default.
- W2021982292 hasConceptScore W2021982292C126322002 @default.
- W2021982292 hasConceptScore W2021982292C141071460 @default.
- W2021982292 hasConceptScore W2021982292C151032500 @default.
- W2021982292 hasConceptScore W2021982292C2776694085 @default.
- W2021982292 hasConceptScore W2021982292C2778041864 @default.
- W2021982292 hasConceptScore W2021982292C2778729363 @default.
- W2021982292 hasConceptScore W2021982292C2780923524 @default.
- W2021982292 hasConceptScore W2021982292C71924100 @default.
- W2021982292 hasConceptScore W2021982292C72563966 @default.
- W2021982292 hasConceptScore W2021982292C88879693 @default.